EE157 Assessing the Cost-Effectiveness of Sodium Phenylbutyrate/Taurursodiol and Oral Edaravone in the Treatment of Amyotrophic Lateral Sclerosis
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.456
https://www.valueinhealthjournal.com/article/S1098-3015(24)00571-0/fulltext
Title :
EE157 Assessing the Cost-Effectiveness of Sodium Phenylbutyrate/Taurursodiol and Oral Edaravone in the Treatment of Amyotrophic Lateral Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00571-0&doi=10.1016/j.jval.2024.03.456
First page :
Section Title :
Open access? :
No
Section Order :
11800